Katherine Tsaioun
Corporate Officer/Principal chez Alzheimers Drug Discovery Foundation
Profil
Katherine Tsaioun is the founder of Cyprotex US LLC, which was founded in 2006.
Dr. Tsaioun is also the founder of BioTek Instruments LLC.
Currently, Dr. Tsaioun is a Member-Scientific Review Board at Alzheimers Drug Discovery Foundation.
Previously, Dr. Tsaioun worked as an Executive Director & Chief Scientific Officer at Cyprotex Ltd.
from 2010 to 2012.
Dr. Tsaioun received a doctorate degree from Tufts University.
Postes actifs de Katherine Tsaioun
| Sociétés | Poste | Début |
|---|---|---|
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Corporate Officer/Principal | - |
Anciens postes connus de Katherine Tsaioun
| Sociétés | Poste | Fin |
|---|---|---|
| CYPROTEX PLC | Directeur Technique/Scientifique/R&D | 04/09/2012 |
BioTek Instruments LLC
 BioTek Instruments LLC Medical SpecialtiesHealth Technology BioTek Instruments LLC provides microplate instrumentation and software for the drug discovery, genomics and proteomics and life science research fields. Its products include automated microplate detection systems for absorbance, fluorescence and chemiluminescence measurements, along with a complete line of automated washers, dispensers and pipetting systems, microplate stackers and robots, and data analysis software. BioTek Instruments was founded by Norman Alpert in 1968 and id headquartered in Winooski, VT. | Fondateur | - |
Cyprotex US LLC
 Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Fondateur | - |
Formation de Katherine Tsaioun
| Tufts University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Cyprotex Ltd.
 Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
BioTek Instruments LLC
BioTek Instruments LLC Medical SpecialtiesHealth Technology BioTek Instruments LLC provides microplate instrumentation and software for the drug discovery, genomics and proteomics and life science research fields. Its products include automated microplate detection systems for absorbance, fluorescence and chemiluminescence measurements, along with a complete line of automated washers, dispensers and pipetting systems, microplate stackers and robots, and data analysis software. BioTek Instruments was founded by Norman Alpert in 1968 and id headquartered in Winooski, VT. | Health Technology |
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Health Technology |
Cyprotex US LLC
Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Commercial Services |
